Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review

24Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

One of the most effective cancer therapies, cancer immunotherapy has produced outstanding outcomes in the field of cancer treatment. However, the cost is excessive, which limits its applicability. A smart way to address this issue would be to apply the knowledge gained through immunotherapy to develop strategies for the immunoprevention of cancer. The use of cancer vaccines is one of the most popular methods of immunoprevention. This paper reviews the technologies and processes that support the advantages of cancer immunoprevention over traditional cancer immunotherapies. Nanoparticle drug delivery systems and nanoparticle-based nano-vaccines have been employed in the past for cancer immunotherapy. This paper outlines numerous immunoprevention strategies and how nanotechnology can be applied in immunoprevention. To comprehend the non-clinical and clinical evaluation of these cancer vaccines through clinical studies is essential for acceptance of the vaccines.

Cite

CITATION STYLE

APA

Koyande, N. P., Srivastava, R., Padmakumar, A., & Rengan, A. K. (2022, October 1). Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review. Vaccines. MDPI. https://doi.org/10.3390/vaccines10101727

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free